All the news Showing 8 of 8 articles from: AASLD 2018Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Side effects Do Patients with Chronic Liver Disease Face Higher Drug-Induced Liver Injury Risk? MedPage Today / 14 November 2018 NAFLD Novel Thyroid Beta Receptor Agonist Cut LDL-C in NAFLD Patients MedPage Today Gastroenterology / 14 November 2018 Treatment outcomes DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link? Monthly Prescribing Reference / 14 November 2018 Screening and testing policy Universal HCV Screening on the Way? MedPage Today / 12 November 2018 Hepatocellular carcinoma (HCC) Five Years of Regular Aspirin Use Helps Prevent Common Liver Cancer AASLD press release / 12 November 2018 Deciding when and how to treat HCV Hepatitis C treatment can be shortened in 50 percent of patients, study finds Eurekalert Inf Dis / 12 November 2018 Access to medicines & diagnostics The Medicines Patent Pool signs licence with AbbVie to expand access to key hepatitis C treatment, glecaprevir/pibrentasvir Medicines Patent Pool / 12 November 2018 Life after the cure HCV reinfection uncommon in injection drug users after treatment Healio / 12 November 2018 ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive